Melanotan I (MT-1) × glowaminos peptides — lab test, May 2026
COA COA-2026-412627 matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
UQJ4JZ9Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 10.54 mg
105% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.6 mg using the measured mass, against 2.5 mg on the label — 5% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | COA-2026-412627 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 11 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Melanotan I (MT-1) from glowaminos peptides, performed by ILS Laboratories on May 30, 2026. Reported purity: 99.61%. Net content: 10.54 mg against 10 mg labeled (105% of label). Heavy metals: ICP-MS: Arsenic 0.242 ppm, Cadmium Not Detected, Lead 0.1244 ppm, Mercury 0.286 ppm, Chromium 0.206 ppm — all Pass. Batch GL-010129. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Melanotan I (MT-1) from glowaminos peptides
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| GL-010197 | 9 Jul 2026 | ILS Laboratories | 99.94% | 105% | ✓ Lab-verified |
| GL-010071 | 18 Mar 2026 | freedomdiagnosticstesting.com | 99.655% | 119% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion